Clinical Trial Update: Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait

View source ↗

Summary

A completed clinical trial update from NHLBI evaluating biomarkers related to venous thrombosis in people with sickle cell disease and sickle cell trait.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercoagulable State
• Sickle Cell Disease
• Sickle Cell Trait
• Venous Thromboembolism

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Disease, Venous Thrombosis | Status: COMPLETED